MT-CO2 and Parkinson disease: However, our data suggests this is a losing battle, as PD cases also show an increase in the formation of de novo nonsynonomous MTND1, MTND2, MTCO2, MTCO3, and MTCYTB variants in the SNpc compared to controls.